← Back
$LYEL All transactions

Lyell Immunopharma, Inc.

A

$ Value

$0

Shares

8,000

Price

$0

Filed

Aug 22

Insider

Name

Hill Stephen J.

Title

Chief Operating Officer

CIK

0001866154

Roles

Officer

Transaction Details

Transaction Date

2025-08-20

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

16,849

Footnotes

Pursuant to performance-based restricted stock units granted to the reporting person on February 9, 2024, 4,000 shares were issued on the Transaction Date upon the achievement of certain performance criteria certified by the compensation committee of the Issuer's board of directors on the Transaction Date and 4,000 shares will be issued on August 20, 2026, subject to the reporting person providing service through such date. | Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. | The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $10.49 to $10.64 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Filing Info

Accession No.

0001415889-25-022746

Form Type

4

Issuer CIK

0001806952

Hill Stephen J.'s History

Date Ticker Type Value
2025-11-10 LYEL $2K
2025-10-27 LYEL A $0
2025-08-21 LYEL $11K
2025-08-20 LYEL A $0
2025-08-12 LYEL $972
2025-08-11 LYEL $958

Other Insiders at LYEL (90d)

No other insider activity at this issuer in the last 90 days.